Infection by HIV-1 requires protein-protein interactions involving gp120, CD4 and CCR5. We have previously demonstrated that the transferred nuclear Overhauser effect (TRNOE), in combination with asymmetric deuteration of a protein and a peptide ligand can be used to detect intermolecular interactions in large protein complexes with molecular weights up to~100 kDa. Here, using this approach, we reveal interactions between tyrosine residues of a 27-residue peptide corresponding to the N-terminal segment of the CCR5 chemokine receptor, and a dimeric extended core YU2 gp120 envelope protein of HIV-1 complexed with a CD4-mimic miniprotein. The TRNOE crosspeaks in the ternary complex were assigned to the specific Tyr protons in the CCR5 peptide and to methyl protons of isoleucine, leucine and/or valine residues of gp120. Site directed mutagenesis combined with selective deuteration and TRNOE resulted in the first discernment by a biophysical method of specific pairwise interactions between gp120 residues in the bridging sheet of gp120 and the N-terminus of CCR5.
Introduction
The binding of HIV-1 to leukocytes is mediated by the gp120 envelope glycoprotein of the virus and occurs by a multi-step mechanism, involving two different receptor molecules, CD4 and a chemokine receptor, which can be either CCR5 or CXCR4. The CCR5 receptor is the major co-receptor used by HIV-1 for infection. When CD4 binds to the trimeric spike, which consists of three gp120 and three gp41 envelope proteins, a major conformational change occurs. This exposes the V3 loop of gp120 and a determinant termed the bridging sheet formed by the b2 and b3 strands at the V1/V2 stem and the b19 and b20 strands in the C4 region. Residues in the b2 and b3 strands and their vicinity, in the b19, b20 and b21 strands of the C4 region, as well as in the V3 region have all been implicated in CCR5 binding [1] . On the Abbreviations CCR5, human C-C chemokine receptor 5; CD4, cluster of differentiation 4; CD4M33, a peptide mimic of CD4 used in this study; CXCR4, human C-X-C chemokine receptor 4; gp120, the extra cellular subunit of the HIV-1 envelope glycoprotein; HIV-1, human immuno-deficiency virus type 1; mut gp120 core (+V3), a gp120 core molecule from the JRFL strain with the V3 loop. The construct contains four mutations that alleviated aggregation and lacks V1 and V2 of HIV-1 gp120; mut gp120 core (DV3), same as mut gp120 core (+V3) but lacking the V3 loop; Nt-CCR5 (1-27), a 27 residue peptide that contains two sulfated tyrosine residues and corresponds to the N-terminal region of CCR5, MDYQVSSPIY (SO 3 H) DINY(SO 3 H)YTSEPAQKINVKQ; sCD4, soluble CD4; SPR, surface plasmon resonance; STD, saturation transfer difference; T2, transverse-relaxation time; TRNOE, transferred nuclear Overhauser effect; YU2 gp120core e , an extended 44- 492gp120 core from the YU2 strain which lacks the V1, V2 loops and contains in addition to gp120 core the base of the V3.
basis of recent crystal structures of CCR5 and CXCR4 it is assumed that the V3 binds to a deep pocket formed by the chemokine receptor transmembrane helices and the second extracellular loop of these receptors [2, 3] .
The N-terminal segment of CCR5 contains four tyrosine residues. Sulfation of at least two of these tyrosines is essential for gp120 binding to CCR5 [4] [5] [6] [7] [8] . Peptides corresponding to the CCR5 N-terminal segment (Nt-CCR5), which contain sulfated tyrosine residues at positions 10 and 14, exhibit micromolar binding (K D~1 -10 lM) to a binary complex of gp120 with the CD4 mimic peptide CD4M33 [9] . Nt-CCR5 peptides block HIV-1 infection [7, 8] and CD4/Nt-CCR5 conjugates provided broad protection against viral challenge [10] . It has been assumed that the CCR5 N-terminal segment interacts with the V3 stem and the C4 region [11] .
Some human anti-gp120 antibodies directed against the CCR5 binding site contain sulfated tyrosine residues. The structure of one such antibody 412d in complex with gp120 was solved [12] . This structure reveals a conserved binding site for sulfated tyrosine residues at the base of the V3. It has been assumed that the CCR5 N-terminal segment binds to the same location, and models for gp120-Nt-CCR5 complexes were calculated on the basis of saturation transfer NMR experiments which indicated that the base of V3 is the binding site for the sulfated N-terminal segment of CCR5 [9, 12] . However, models in which Nt-CCR5 interacts mostly with the base of the V3 do not provide an explanation for the role of the bridging sheet in CCR5 binding.
The crystal structures of chemokine receptor published to date lack most of the N-terminal segment of these receptors, which is assumed to be flexible. Moreover, at present there is no direct information about pairwise interactions between the CCR5 and CXCR4 chemokine receptors and gp120. The absence of data on specific pairwise interactions between gp120 and Nt-CCR5 compromises the calculation of highly accurate models. Although site-directed mutagenesis studies revealed contributions of certain amino acid residues in the bridging sheet region of gp120 to Nt-CCR5 binding, the precise interactions are not known [1] .
Previously, using transferred nuclear Overhauser effect (TRNOE) measurements, we were able to observe intermolecular interactions between an Nt-CCR5 peptide and gp120 of the JR-FL strain, JR-FL gp120, in complex with the CD4-mimic peptide, CD4M33 [13] . The observed interactions involved methyl protons of Ile, Leu and Val residues of gp120 and were assigned to the specific aromatic protons in Nt-CCR5(1-27) [MDYQVSSPIY(SO 3 H) DINY(SO 3 H) YTSEPAQKINVKQ]. However, no assignment of the interactions to specific Ile, Leu or Val residues of gp120 could be made at that time. In the present study we use deuteration of gp120 Ile, Leu and Val residues in different combinations and conservative site-directed mutagenesis of Ile, Leu and Val in the bridging sheet to pinpoint specific pairwise interactions between the N-terminus of CCR5 and the C4 region of gp120.
Results
Interaction between gp120 and Nt-CCR5 do not require the V3 loop
To gain information on the contribution of the V3 stem and C4 regions we prepared a JR-FL gp120 core molecule, mut gp120 core (DV3), which in addition to V1/ V2 truncation lacks the V3 loop. To observe intermolecular interactions between aromatic protons of Nt-CCR5 (1-27) tyrosine residues and the gp120 methyl protons using the asymmetric deuteration approach [14] and TRNOE, the aromatic protons of mut gp120 core (DV3) and the valine and isoleucine residues of the Nt-CCR5 (1-27) peptide were deuterated. We successfully used this strategy in the past to observe intermolecular interactions between Nt-CCR5(1-27) and mut gp120 core (+V3) containing the V3 [13] . The TRNOE spectrum measured for the mut gp120 core (DV3)/CD4M33 complex in the presence of a sevenfold molar concentration of Nt-CCR5 (1-27) ( Fig. 1) showed practically the same NOE interactions that were previously observed for mut gp120 core (+V3) (fig. 7 in ref. [13] . Thus we conclude that the gp120 core is mostly responsible for Nt-CCR5(1-27) binding and that the contribution of the V3 is rather minor.
YU2
gp120core e is suitable for NMR studies on gp120-Nt-CCR5(1-27) interactions
The mut gp120 core (DV3) molecule lacks conserved segments at the base of the V3 that form a b-sheet together with the b20/b21 strands at the base of the C4 region. This base helps stabilize the conformation of the gp120 core, especially in the unliganded form [15] . Moreover, mut gp120 core (DV3) lacks a segment, residues 44-87, that was omitted in the first gp120 construct that was crystallized [16] but that has been retained in more recent crystallographic studies. Finally, mut gp120 core (DV3) was unstable at temperatures above 30°C. Kwong et al. [15] designed a gp120-core extended molecule, YU2 gp120core e , that contained the base of the V3 in addition to residues 44-87. We anticipated that the YU2 construct would have improved stability based on the inclusion of conserved segments at the base of the V3. Furthermore, the structure of YU2 gp120 complex with the CD4-mimic peptide CD4M33 has been published [17] . Therefore, we used the same YU2 gp120core e construct designed by Kwong and coworkers in the continuation of our studies.
The 1 H 1D spectrum of YU2 gp120core e showed better dispersion in comparison to mut gp120 core (DV3) in the methyl region of the spectrum in the unliganded form, in complex with CD4M33 and in the presence of Nt-CCR5(1-27) (data not shown). Moreover, this construct showed improved temperature stability and no precipitation was observed after prolonged measurements even at 42°C. We eliminated the EndoHf cleavage to retain the carbohydrates and make the gp120 molecule more similar to native gp120.
gp120core e manifested slightly longer T2 values at pH 5.6 and therefore subsequent measurements were carried out at this pH. Similar to the previously studied mut gp120 core (+V3) construct, the YU2 gp120core e in complex with the CD4M33 peptide and Nt-CCR5(1-27) formed a dimer with an apparent molecular weight exceeding 100 kDa.
I423 from gp120 C4 region is the major isoleucine residue contributing to Nt-CCR5 (1-27) interactions
The goal of the present study was to assign the NOE interactions between gp120 and the tyrosine residues of Nt-CCR5(1-27), first to a specific amino acid type and then to a specific residue in gp120. To specifically observe the interactions of gp120 Ile residues with aromatic protons of Nt-CCR5(1-27), we uniformly deuterated all Leu and Val residues of YU2 gp120core e as well as all of its aromatic amino acids (H-Ile gp120). We then measured the NOE spectrum of this protein in complex with CD4M33 and in the presence of a fiveto sevenfold excess of Nt-CCR5(1-27) with perdeuterated Ile and Val residues using a 50 ms NOE mixing period. NOESY measurements of YU2 gp120core e /Nt-CCR5(1-27) interactions under the same conditions but using a 30 ms period showed practically the same results as those obtained using a 50 ms mixing period. However, more than three times the number of scans were required to obtain a comparable signal-to-noise ratio (data not shown). Thus, we can conclude that spin diffusion does not make a significant contribution to the NOE crosspeaks.
In general the NOE interactions observed for methyl protons are much stronger than those observed for other protons because of the three equivalent methyl protons and their T2, which is considerably longer than other side-chain protons as a result of increased mobility. The extensive deuteration of methyl containing residues other than the type of amino acid under investigation, may also contribute to stronger NOEs due to elimination of relaxation pathways. Thus, the observed intermolecular TRNOEs involving methyl protons may indicate interacting protons up to~6 A apart.
Based on our deuteration strategy, the crosspeaks appearing in the upfield region in F1 (d < 1 ppm) in Fig. 2A are mostly due to interactions of YU2 gp120-core e Ile methyl protons with the tyrosine protons of Nt-CCR5(1-27). The strongest interactions are observed with sY10 d and e protons and with the e protons of sY14. Weaker interactions are observed with Y15 d and e protons. The putative binding site on gp120 for CCR5 includes several Ile residues [1, 18] . Of these residues, I322, I325 at the base of the V3 (I324 and I327, respectively, in YU2) and I420 in the fourth constant region of gp120, C4, were implicated previously in Nt-CCR5-binding using mutagenesis [11] . The I324 residue is not included in the YU2 gp120 extended construct developed by Kwong et al. [15] that is used in the present study. The aromatic tyrosine protons of Nt-CCR5(1-27) were assigned as previously described [13] . As gp120 is a high molecular weight glycoprotein expressed in mammalian cells the gp120 sequential and side-chain assignment cannot be achieved using uniform 13 C, 15 N, and 2 H labeling of the protein and multidimensional heteronuclear NMR spectroscopy. In order to assign the YU2 gp120core e Ile NOE interactions to specific Ile residues of gp120, we employed a conservative site-directed mutagenesis approach and uniform deuteration of valine and leucine residues of gp120. Specifically, we prepared three different YU2 gp120core e mutants: (a) I327L, I420L and I423L. These residues are 55%, 0.4%, and 74% exposed, respectively, in the crystal structure of YU2 gp120 in complex with CD4M33 [17] . Conservative mutation of Ile to Leu was done to minimize the effect of the mutations on the structure and interactions of gp120. The I420L and I423L mutants expressed well in the HEK 293 cells and we isolated 4-5 mg protein per L of culture, while in our hands the I327L mutation could not be stably transfected despite considerable effort. The crosspeaks for the I420L mutant were almost indistinguishable from those of the YU2 gp120core e (Compare Fig. 2A,B ). In contrast, using an identical deuteration scheme (deuteration of valine and leucine residues; 'H-Ile-deuteration scheme'), the I423L mutation resulted in almost complete disappearance of the intermolecular TRNOE peaks between tyrosine protons and protons upfield of 1 ppm (Fig. 2C ). The NOE crosspeaks of the I423L in the H-Ile scheme were very similar to those in the spectrum in which all three methyl containing amino acids Ile, Leu and Val were deuterated (Fig. 2D) .
To compare the intensities of the intermolecular NOEs in the different deuteration schemes and for the different mutants described below, the intramolecular TRNOE between the tyrosine aromatic protons and the b protons of the same aromatic residue served as an internal standard. Accordingly, these intra molecular NOEs are represented at the same contour level in all of the TRNOE spectra in Figs 2-6. We suggest that this is a reliable reference since these very strong crosspeaks appear in all spectra.
When using this approach it is important to demonstrate that the absence of crosspeaks in the aliphatic/ aromatic region in YU2 gp120core e I423L is indeed due to the mutagenesis and the labeling scheme, rather than a change which impairs the gp120/Nt-CCR5(1-27) interaction. Toward this aim, a NOESY spectrum (Fig. 3) was measured for YU2 gp120core e I423L expressed so that only Leu residues are protonated (Ile and Val residues are deuterated). This spectrum reveals intermolecular interactions of the mutant YU2 gp120core e Leu residues with peptide aromatic protons. Comparison with the unmutated YU2 gp120 core e spectrum demonstrates that the NOE crosspeaks previously observed for I423 ( Fig. 2A ) are now observed for L423 in the mutant YU2 gp120core e I423L spectrum (Fig. 3) . Additional crosspeaks are observed in Fig. 3 because in addition to I423 which has been mutated to Leu there are other core Leu residues that make their own interactions with the Tyr protons of Nt-CCR5(1-27) (see Fig. 5A below) . Together, the data in these experiments provide unequivocal support for the conclusion that the I423L mutation did not prevent the interaction of residue 423 in the protein with Tyr protons in Nt-CCR5 and that the reason for the absence or presence of the crosspeaks is the deuteration scheme employed. To test this conclusion the binding affinities YU2 gp120core e I423L and other constructs with mutations in Leu and Val residues in the YU2 gp120core e were measured directly using surface plasmon resonance (SPR) experiments as reported below.
To further investigate the loss of intermolecular NOE intensities upon the mutation of I420 and I423 and assess their relative contributions to the intermolecular interactions we examined a slice (column) through the most intense intermolecular TRNOE crosspeak (column 2630 at F2 = 7.16 ppm). In this comparison, the intramolecular TRNOE between the aromatic protons of Nt-CCR5(1-27) tyrosine residues and their b protons as well as the inter-residue intramolecular NOE between Y15 aromatic proton and Thr16 methyl protons served as internal standards. As can be seen in Fig. 4A the I423L mutation resulted in~60% reduction in the NOE between Nt-CCR5(1-27) Y10 and g120 Ile residues (compare the black and blue curves). In contrast, the I420L mutation resulted in only a small change in the intermolecular NOE intensity NOE between Nt-CCR5(1-27) Y10 and gp120 Ile residues (compare the black and red curves in Fig. 4A ), suggesting that I420 has only a minor contribution, if any, to the Nt-CCR5(1-27) interaction with gp120. Interestingly, the I423L mutation resulted in a significantly stronger NOE at 1.9 ppm. Some possible reasons for these effects are presented in the Discussion.
Based on the observations presented in Fig. 2A -D and Fig. 4A , we conclude that I423 is the major Ile residue contributing to gp120 interactions with the aromatic protons of the Nt-CCR5 receptor peptide, whereas I420 interacts very weakly if at all with these positions in Nt-CCR5(1-27). The methyl protons of I423 interact strongly with sY10 and with the e protons of sY14. This is in agreement with the almost complete burial of I420 (0.4% exposure) and the considerable surface exposure of I423 (74%). This experiment also indicates that other Ile residues of gp120, such as I327 do not interact with Nt-CCR5(1-27) aromatic residues to any significant extent.
L122 interacts with Nt-CCR5(1-27) tyrosine residues
To examine whether gp120 Leu residues contribute to the interaction with aromatic residues of Nt-CCR5 a similar approach was taken. We deuterated the Ile and Val residues of gp120 along with its aromatic residues to observe only the interaction of the methyl protons of gp120 Leu residues with tyrosine protons of Nt-CCR5(1-27). The TRNOE spectrum measured for the gp120/CD4M33/Nt-CCR5(1-27) complex indicates that gp120 Leu methyl protons do interact with the tyrosine aromatic protons of Nt-CCR5, although considerably more weakly than I423 (Fig. 5A ). These intermolecular TRNOEs are assigned to interactions with the e and d protons of sY10 and the e protons of sY14. Weaker interactions are observed with Y15 e and d protons. Based on previous mutagenesis studies L122 is close to residues in the b2 strand of the bridging sheet implicated in CCR5 binding, such as K121 and T123, although the mutation L122S had no effect on CCR5 binding [1] . To specify the contribution of L122, we engineered a conservative mutation from Leu to Ile at this position in YU2 gp120core e . The TRNOE spectrum of the YU2 gp120core e L122I mutant with all aromatic amino acid, Ile and Val residues deuterated and Leu residues protonated ('H-Leu'-labeling) exhibited a significant decrease in the intermolecular TRNOE interactions with Nt-CCR5(1-27) aromatic protons ( Fig. 5B) while maintaining all intra-Nt-CCR5 (1-27) TRNOEs and some TRNOE interactions with an unidentified gp120 residue. Examination of the column through the strongest intermolecular NOE of the YU2 gp120core e Leu residue (column 2615 at F2 = 7.18 ppm Fig. 4B ) shows that the observed NOE interactions of gp120 Leu residues with the tyrosine residues of Nt-CCR5(1-27) is two to three times weaker than that observed for Ile residues. Furthermore, the L122I mutation L122I resulted in~60% reduction in crosspeak intensity (compare black and red curves). Thus, we conclude that while L122 interacts with Nt-CCR5(1-27) the interaction is not as strong as that of I423. Based on the partial (Fig. 2B) . Practically no change is observed in the 0.6-0.8 ppm region. Blue -the same column as above from the NOESY spectrum of YU2 gp120core e I423L mutant and the same labeling scheme (Fig. 2C) . A very pronounced decrease in crosspeak intensity is observed in the 0. YU2 gp120core e aromatic protons as well as Leu and Ile protons are deuterated. Red -the same column as above from the NOESY spectrum of YU2 gp120core e V120I mutant and the same labeling scheme (Fig. 6B) . Blue -the same column as above from the NOESY spectrum of YU2 gp120core e V200I mutant and the same labeling scheme (Fig. 6C) . Purple -the same column as above from the NOESY spectrum of YU2 gp120core e V120I; V200I double mutant and the same labeling scheme (Fig. 6D ). Significant decrease in crosspeak intensities is observed for all Val mutants. The crosspeaks at~3 ppm which are due to intra-tyrosine NOE between the aromatic and the tyrosine b protons serve as internal standard.
disappearance of the crosspeaks we conclude that L122 interacts primarily with the e and d protons of sY10.
Probing the interactions of Val residues with Nt-CCR5(1-27)
To examine the contribution of gp120 Val residues to Nt-CCR5 binding, we uniformly deuterated all Ile and Leu residues of the protein in addition to all of its aromatic amino acids ('H-Val'-labeling). The TRNOE spectrum shows extensive interactions of Val methyl protons with the aromatic residues of Nt-CCR5(1-27) (Fig. 6A) . Unlike Ile and Leu methyl, which showed the strongest interactions with sY10, approximately equal intensities intermolecular NOEs are observed with sY10, sY14 and Y15 excluding the weak interactions with sY14 d protons. Potential candidates for these interactions are V120 and V200 from the b2 and b3 strands, respectively. The valine methyl protonsaromatic protons interactions in the V120I mutant are somewhat weaker than the parent YU2 gp120core e as judged by the TRNOE spectrum in the F2 = 6.7-7.3 and F1 = 0-1.00 region when only Val methyl residues were protonated (compare Fig. 6A,B) . This suggests that the methyl protons of V120 do interact with the aromatic protons of Nt-CCR5(1-27) and that there is another gp120 Val residue involved in interaction with Nt-CCR5(1-27). Indeed mutation of V200 to Ile also caused pronounced decrease in crosspeak intensity (compare Fig. 6A,C) . Analysis of the NOESY spectrum of the V120I, V200I gp120 double mutant (compare Fig. 6A,D) resulted in almost complete disappearance of the intermolecular NOEs attributed to gp120 Val methyl protons using the H-Val deuteration scheme. This disappearance suggests that these two valine residues contribute most of the interactions of gp120 valine residues with Nt-CCR5 Y and sY residues. Similar conclusion about the participation of both V120 and V200 in YU2 gp120core e could be drawn also from the data in Fig. 4C .
Binding affinities of YU2
gp120 Core e mutants with mutations of residues that were found to interact with Nt-CCR(1-27) tyrosine aromatic protons To determine the binding affinities of the YU2 gp120-core e proteins studied by NMR we measured binding to Nt-CCR5(1-27) using SPR approaches. In the SPR measurements a biotinylated form of Nt-CCR5(1-27) was immobilized on a streptavidin precoated sensor chip and the various mutant YU2 gp120core e proteins were allowed to flow over the chip. Binding with both gp120 alone and gp120/CD4M33 complexes was measured. The K D s of the parent YU2 gp120core e protein and its CD4M33 complex with biotinylated Nt-CCR5 (1-27) were 36 AE 2 lM and 6.2 AE 0.4 lM, respectively ( Table 1 ). The latter affinity was quite similar to that previously obtained with the JR-FL protein (1.4 AE 0.3 lM). More critically, the YU2 gp120core e I423L construct had K D values (76 AE 4 lM and 11 AE 1 lM) that did not deviate significantly from those of the parent YU2 gp120core e protein. Similar results were observed for all other constructs (Val and Leu mutants) with mutations at residues that were observed to interact with Nt-CCR5(1-27). Constructs that did not reveal interactions with the Nt-CCR5 tyrosine groups were not examined. These experiments indicate that the conservative mutations we are studying do not significantly change the interactions of the gp120 protein with the Nt-CCR5 tail of the receptor.
Discussion
The V3 stem is not essential for gp120 interactions with Nt-CCR5(1-27)
The V3 and the bridging sheet formed by the b2, b3 and the C4 regions of gp120 previously have been implicated in HIV-1 co-receptor binding [1, 18] . Crystal structures of CXCR4 and CCR5, in complex with their respective chemokine ligands, have led to the hypothesis that the V3 crown and stem binds to a binding pocket formed by the transmembrane helices and the second extracellular loop of this receptor [2, 3] . In the present study, we investigated the binding of the N-terminal segment of CCR5 to gp120. Our initial goal was to establish conditions that would allow dissection of the contributions of V3 and the bridging sheet to Nt-CCR5 binding. By using a gp120 JR-FL construct lacking the entire V3, we showed that the V3 is not essential for Nt-CCR5(1-27) binding and that the NOEs observed between Nt-CCR5(1-27) and gp120 lacking or containing the entire V3 and are practically indistinguishable (Fig. 1A and [13] ).
To further investigate gp120/Nt-CCR5(1-27) pairwise interactions we chose a gp120core construct, YU2 gp120core e, that lacks the V3 crown and stem. YU2 gp120core e still contains the base of the V3 which forms important stabilizing interactions with the gp120 core [15] . This construct enabled us to observe possible interactions of Nt-CCR5(1-27) residues with residues both at the base of the V3 and in the bridging sheet. The YU2 gp120core e construct in complex with CD4M33 binds Nt-CCR5(1-27) with a K D that is less than fivefold higher than that of mut gp120 core (+V3) containing the entire V3, supporting our conclusions that the V3 crown and stem are not essential for gp120 binding to Nt-CCR5(1-27) and make only minor contribution to the binding energy.
A modified labeling strategy focused on NOE interactions between specific types of methyl containing residues in gp120 and tyrosine protons of Nt-CCR5 In our previous study on the mut gp120 core (+V3) construct we demonstrated that Ile residues made a major contribution to the aliphatic methyl-tyrosine interactions between this protein and Nt-CCR5(1-27) as deuteration of Ile residues of gp120 resulted in considerably weaker crosspeaks between the protein and peptide surrogate [13] . In the methyl region of the NOESY spectrum for a protein interacting with a peptide, many residues can contribute interactions. Therefore, it is sometimes quite difficult to decipher the loss of crosspeak intensity when an individual residue is deuterated. In contrast a much more direct approach is to simplify the measured NOE spectrum by eliminating contributions in a certain spectral region of all amino acid types except the one of interest. Anglister et al. [19] previously used this approach to study the interactions of aromatic amino acids of antibodies with peptide antigens. For example, by deuterating tryptophan and phenylalanine residues of the antibody, the NOE interactions of tyrosine residues (with slight interference from histidine) could be observed. Here we showed that this strategy could be used to study the interactions of the methyl protons of Ile, Leu and Val of gp120 with tyrosine aromatic protons of Nt-CCR5(1-27). Deuteration of Leu and Val residues of gp120 revealed interactions of Ile methyl protons and similarly deuteration of Ile and Val, or of Ile and Leu revealed interactions of Leu methyl protons or Val methyl protons, respectively. This deuteration scheme reduced the number of crosspeaks in the methyl region and enabled us to conclude that methyls of Ile, Leu and Val residues in YU2 gp120-core e interact with the tyrosine aromatic protons of Nt-CCR5 .
By analyzing these spectra we note that methyl groups of Ile and Val residues of YU2 gp120core e have strong interactions with Nt-CCR5(1-27) tyrosine protons whereas Leu methyls make fewer and weaker contacts (Compare Figs 2A, 4A and 5A). All of these spectra exhibit the same intramolecular NOEs between protons in Nt-CCR5(1-26) and the tyrosine protons. This served as an internal calibration between the spectra of the different YU2 gp120core e constructs.
Assignment of crosspeaks to specific Ile, Leu or Val residues
The strategy discussed above allowed us to isolate interactions between methyls of either Ile, Leu or Val protons. It also provided a foundation for assigning such interactions to a specific residue in the protein sequence or to rule out such an interaction. This was accomplished using very conservative mutations and the deuteration scheme described above. These conservative mutations resulted in almost no or only minor changes in K D (Table 1 ). The selection of residues for mutagenesis was guided by the crystal structure of YU2 gp120 in complex with CD4M33 [17] and we mutated residues located in the bridging sheet that were found to be exposed to the solvent. We found that I423, Leu122, and V200 interact with sY 10 d and e protons of sY 14 and V120 interacts with Y
15
. By analyzing slices through the interacting aromatic proton, we could gain quantitative information on the contribution of a given methyl to a particular crosspeak. In this way, we ascertained that deuteration of the I423L mutant reduced the crosspeak by more than 60% whereas deuteration of V120I and V200I mutants led to~a 50% reduction in the crosspeaks. The remaining signals could be contributed by combination of: (a) incomplete deuteration which is of the order of 7% [13] , (b) a shoulder created due to the Lorentzian shape of the resonance lines of alanine and threonine residues of gp120 as well as T16 of the peptide and possible minor contributions by other Ile residues. In comparison to the spectrum of parental gp120 with 'H-Ile'-labeling, the I423L spectrum differs in that the Ile is mutated to Leu and also in that the Leu in position 423 is deuterated. This additional deuteration may increase the NOE intensities of nearby residues as a result of the localized elimination of relaxation pathways. The strong change in NOE intensities of binding residues other than Ile, such as the significantly stronger NOE at 1.9 ppm (Fig. 4A-blue line) , suggests that I423 is a central residue in the binding interface between Nt-CCR5(1-27) and gp120. Replacement of this residue by Leu and its deuteration may increase the NOEs of nearby residues such as M434 and Q422, strengthening the relative contribution of these two residues to binding as the result of the mutation and of the weakening of the hydrophobic interactions that is caused by deuteration [20] .
In contrast to the above determination of interactions with methyl groups from specific gp120 residues, the NMR studies seem to rule out Ile420 as an interaction partner. This is probably due to limited surface exposure of this residue (only 0.4%). To our knowledge, this is the first time that a biophysical method was used to define pairwise interactions between Nt-CCR5 residues and gp120 residues. The method is powerful and easily applicable to protein complexes up to a molecular weight of~100 KDa. It will be especially useful for complexes involving interactions with membrane proteins, which remain refractive to crystallization.
The NOEs between specific protons will provide valuable constraints in modeling the gp120/CD4/CCR5 complex. Incorporating upper and lower distances between four residues of the envelope protein and three different tyrosines of the receptor should result in a greatly improved structure. Now that this approach has been established, we believe that such a model will be more accurate if constraints involving Lys, Arg and perhaps Met and Thr residues are also included. These studies are now underway in our laboratory.
The bridging sheet of gp120 interacts with Nt-CCR5 The bridging sheet that is formed upon CD4 binding has been implicated in the entire CCR5 binding [1, 18] . Here, we demonstrate that residues in the bridging sheet interact directly with the tyrosine residues in the N-terminal segment of the coreceptor. These include the sTyr10, sTyr14 and Tyr15. The residues that were found to interact with these tyrosine residues are I423 in C4, V120 and L122 in b2 and V200 in b3. These four residues together with M434 form a large almost continuous hydrophobic surface on gp120 surrounded by positively charged and hydrophilic residues (Fig. 7) . This surface is reminiscent of the binding site of CCL5 for the same CCR5 segment [21] . When bound to CCL5, the side chain of the three Nt-CCR5(1-27) tyrosine residues sY10, sY14 and Y15 form a cluster that interact extensively with I15, L19, and V49 of the chemokine. These hydrophobic amino acids were found to be evolutionary conserved in CC chemokines. If similar clustering of the sTyr10, sTyr14 and Tyr15 side chains exists also in the gp120 complex with Nt-CCR5 this might explain why the four methyl containing residues identified above interact with more than one tyrosine residue in Nt-CCR5(1-27). Upon initial analysis, it may seem unlikely that methyl groups of four different aliphatic residues interact with the aromatic protons from sY 10 , sY 14 and Y
. As seen in Fig. 7 , the pocket in gp120 lined by I423, Leu122, V120 and V200 is fairly wide and some of the methyl groups residues are as far as 12 A from each other. However, the d and e protons of a phenol ring are about 4.5 A apart. We presume that during the exchange between the bound and free states of the peptide, rapid rotation of the phenolic side chain occurs causing the two protons in the d and e position to become magnetically equivalent. They are not resolved in our NOESY spectra. Since these protons can exhibit an NOE interaction with any methyl proton that is within up tõ 6 A, the ring protons can, in principle, interact with Fig. 7 . Surface representation of the gp120 YU2 bridging sheet according to the crystal structure of gp120YU2/CD4M33 complex [17] . Coloring scheme: Hydrophobic residues -green; positively charged residues -blue; negatively charged residues -red polar residues -orange. The residues found in the present study to interact with Nt-CCR5 are dotted.
methyl groups on different residues that are separated by 8-12 A. We believe this accounts for the many methyl-tyrosine NOEs we observe.
Among the four methyl containing residues, I423 has the strongest NOE interactions with Nt-CCR5 as seen in Fig. 4 when the intensity of the NOE is compared to that of the intra molecular NOE between the aromatic protons of Nt-CCR5 and their b-protons and also as can be judged by the signal to noise ratio in the he traces of the columns presented in this figure. This can be explained by the central location of I423 and its considerable solvent exposure. The NOE of the gp120 Val residues are weaker and the NOEs of L122 are the weakest.
The residue to residue mapping of the binding site for Nt-CCR5(1-27) is in general agreement with previous mutagenesis studies carried out by Sodroski and coworkers [1] who identified the bridging sheet as being important for CCR5 binding. A comparison between the residues identified as being involved in CCR5 by Sodroski and coworkers [1, 18] and Nt-CCR5 binding in our study is presented in Fig. 8 . The study of Sodroski and coworkers [1] underlined the importance of many positively charged residues in gp120 for interaction with Nt-CCR5. The role of these residues was not investigated in the present study. Although the hydrophobic surface revealed in the present study was not discovered by Sodroski and coworkers in their early studies [1] the prominent contribution of I423 to Nt-CCR5 binding is in agreement with mutagenesis studies. Dragic and coworkers [11] , Rizzuto and Sodroski [18] and Lee and coworkers [22, 23] identified the residues in the segment R419-Q422 as important for CCR5 and Nt-CCR5 binding although mutation of I423 was not reported. Doms and coworkers found that I423 was important for YU2 binding to CCR5 [24] . Interestingly V200, which was found to interact with Nt-CCR5 in the present study, is close to T202, a residue found to be important for CCR5 binding by Doms and coworkers [24] .
Previous docking models of Nt-CCR5 and gp120 [9, 12] do not agree with the interactions experimentally observed in the presented study (summarized in Fig. 8 ). These modeling studies relied almost exclusively on mutagenesis and saturation transfer NMR studies that revealed the importance of positively charge residues in Nt-CCR5 binding. Accordingly, in these models Nt-CCR5 peptides interact mostly with the base of V3 and with positively charged residues at the base of C4 (R419 and R440). Since the contribution of the methyl containing residues V120 L1222 and V200 was not known when the modeling was carried out, they could not be included. I423 does not interact with Nt-CCR5 in the model calculated by Kwong, Bewley and coworkers [12] and interacts with Nt-CCR5 P8 in the model calculated by Schnur et al. [9] . Overall, in contrast with the conclusions of previous analyses, in the present study the binding site for Nt-CCR5 includes the bridging sheet and is shifted away from the base of the V3. This discrepancy suggests that the results of the mapping of residues involved in binding by saturation transfer difference (STD) NMR experiments is not sufficient to obtain reliable models and must be used cautiously taking into account the inherent limitations of this method. We believe that the TRNOE/asymmetric deuteration strategy should be applicable to any system where STD measurements can be made and unlike the STD analysis provides direct evidence for pairwise interactions. Currently, we are extending the approaches discussed in this communication to elucidate additional pairwise interactions between Nt-CCR5(1-27) and gp120 in order to construct a more accurate structural model for Nt-CCR5(1-27) complexed with gp120. It is reasonable to hypothesize that the final model will include both the positively charged zone near the base of C4 and the hydrophobic patch in the bridging sheet.
Materials and methods
Expression, labeling and purification of gp120 The V1V2 loop (123-199) of gp120 was replaced by GG and the V3 stem and crown regions (301-325) were replaced by GGSGSG and cloned into a pIRES vector. The gene was chemically was synthesized by GenScript, USA. YU2 gp120 core e mutants were generated, using the Quickchange Lightning Site-Directed Mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA). All YU2 gp120 core e variants were stably transfected to HEK293S cells lacking N-acetyl glucosaminyl transferase I (GnTI À HEK293S cells) resulting in a protein homogenously glycosylated with Man 5 GlcNAc 2 glycans at sites normally occupied by complex or hybrid glycans. Cells were transfected using the calcium phosphate method and subjected to a gradual puromycin selection up to 50 lgÁmL
À1
. In this study, the protein was not treated with endoglycosidase-H to remove glycan molecules and we used glycosylated YU2 gp120 core e of~65 kDa for our investigation.
Expression and purification were done according to previously described methods with a few modifications [25] . The expression of deuterated YU2 gp120 core e was achieved by growing the stably transfected GnTI-HEK293S cells in DMEM medium prepared in our laboratory from deuterated amino acids (Cambridge Isotope Laboratories, Tewksbury, MA, USA) and tissue-culture grade unlabeled amino acids (Sigma-Aldrich, St. Louis, MO, USA). Stably transfected cell lines were grown for 7 days in the in-house labeled DMEM medium. Supernatant was harvested, passed through a 0.45 lm filter and the labeled YU2 gp120 core e was purified as briefly described below [25] . gp120core e residues implicated in CCR5 and Nt-CCR5 binding in different studies (A) The four methyl containing residues in the YU2 gp120core e that were found to interact with Nt-CCR5(1-27) in the present study. (B) The YU2 gp120core residues found to effect CCR5 binding using site directed mutagenesis [1] . (C) The YU2 gp120 residues implicated in Nt-CCR5 binding by Kwong, Bewley and co-workers [12] . (D) The YU2 gp120 residues implicated in Nt-CCR5 binding in our previous studies [9] . Residues implicated in CCR5 or Nt-CCR5(1-27) binding are colored red. (E) The secondary structure of gp120. The YU2 gp120core e residues identified in the present study as interacting with Nt-CCR5(1-27) are located in the bridging sheet and colored black.
YU2 gp120 core e and its variants were purified in several steps, the first of which was on a Cibacron column (Blue Sepharose 6 Fast Flow; GE Healthcare Chicago, IL, USA). The eluent was then passed through a benzamidine column (HiTrap Benzamidine FF; GE Healthcare) to remove serine proteases. The YU2 gp120 protein was then further purified with a nickel column (HisTrap FF; GE Healthcare), after which the His_tag was removed by TEV protease cleavage. The TEV protease containing a His_tag was removed with a second nickel column. Finally, the proteins were purified by size exclusion chromatography, with a Superdex 200 column (HiLoad 16/600 Superdex 200, preparative grade; GE Healthcare). Final yields of the > 95% pure protein were~4-5 mgÁL À1 . gp120core e /CD4M33 complex samples containing a five-to seven-fold molar ratio of Nt-CCR5(1-27). Protein concentration was between 88-302 lM. An increased number of scans were used for the more dilute protein samples. Formation of the gp120/ CD4M33 complex was ensured by adding between 20 and 50% molar excess of CD4M33. This was followed usually by dialysis to remove excess CD4M33 before adding Nt-CCR5(1-27). The aromatic amino acids H, F, W and Y were deuterated in all gp120 preparations. Nt-CCR5(1-27) in all samples was deuterated on [I,V]. All NMR measurements on 
NMR sample preparation

Peptide synthesis
CD4M33 and Nt-CCR5(1-27), sulfated at Y10 and Y14 (MDYQVSSPIY(SO 3 )DINY(SO 3 )YTSEPAQKINVKQ), were synthesized as described previously [9, 26] .
NMR measurements
All NMR spectra were measured at 310 K on a Bruker AVIII 800 MHz spectrometer equipped with a 5 mm Triple-Resonance Inverse CryoProbe with Z-gradients (Bruker BioSpin GmbH, Rheinstetten, Germany). Assignments of the chemical shifts of Nt-CCR5(1-27) residues were carried out as previously described [13] by adapting assignments made at pH 8-5.6. Data were processed and analyzed using TOPspin. The NOESY mixing time was 50 ms to minimize spin diffusion. Residual water magnetization was suppressed with a presaturation pulse using minimal power. For a T1q-filtered NOESY in the indirect F1 dimension to measure intermolecular NOEs, we added an 8 ms spin-lock pulse to the standard NOESY experiment. This spin-lock pulse was added after the third 90°pulse and its phases are: y y y y (or in Bruker's convention 1 1 1 1) . A power level that resulted in a 90°pulse of 70 ls was used.
Transverse relaxation (T2) measurements T2 measurements were carried out at 310 K using a standard spin-echo experiment on a complex of 107 lM YU2 gp120 core e deuterated at Y, W, F, H, Ile and Leu with a 1 : 1 molar ratio of CD4M33 and sevenfold molar concentration of Nt-CCR5 deuterated at V and I.
Surface plasmon resonance measurements
Binding affinities (K D ) were determined by SPR using a Biacore T200 instrument (Biacore AB, Uppsala, Sweden). All experiments were carried out at 298 K using SPR buffer (20 mM sodium phosphate buffer pH 5.6, 50 mM NaCl, 3 mM EDTA, 0.005% Tween).
Biotinylated Nt-CCR5(1-27) was immobilized on a streptavidin coated chip (Biacore Sensor Chip SA, GE Healthcare, Chicago, IL, USA). The immobilization procedure was allowed to continue until~200 RU of biotinylated Nt-CCR5 (1-27) were attached to the streptavidin-precoated surface of the chip. A blank sensor surface without an immobilized peptide served as a negative control and as a reference for the binding interaction. Binding was then measured using serial dilutions of YU2 gp120core e or the YU2 gp120core e /CD4M33 complex (concentration ranging from 0.078 to 40 lM), which was injected over the peptide-immobilized surface at a flow rate of 30 lLÁmin À1 and 200 sec contact time. Due to the fast off-rate, regeneration between runs was done with 1 M NaCl for 30 s at 30 lLÁmin
À1
. Data were analyzed using Biacore T200 evaluation software after subtraction of a blank channel (negative control), using equilibrium analysis or a Langmuir 1 : 1 kinetic model.
